1 / 32

Cardiovascular Drugs - Angina, MI & Anti-arrhythmics

Cardiovascular Drugs - Angina, MI & Anti-arrhythmics. by Josie Hough and Steven McFarlane. Angina Prevention/Treatment. Reduce cardiovascular risk factors: Reduce BP Reduce cholesterol Smoking cessation Decrease metabolic demand of LV: Reduce heart rate Reduce arterial pressure

rian
Download Presentation

Cardiovascular Drugs - Angina, MI & Anti-arrhythmics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cardiovascular Drugs- Angina, MI & Anti-arrhythmics • by Josie Hough and Steven McFarlane

  2. Angina Prevention/Treatment • Reduce cardiovascular risk factors: • Reduce BP • Reduce cholesterol • Smoking cessation • Decrease metabolic demand of LV: • Reduce heart rate • Reduce arterial pressure • Reduce ventricular size • Increase coronary blood flow

  3. Treatment Options – Organic Nitrates • Glyceryl Trinate (GTN) & Isosorbide Mononitrate (ISMN) • Mechanism of Action • Nitrovasodilators (metabolised) NO. • NO activates guanylyate cyclase. • Guanylate cyclase coverts GTP cGMP. • cGMP (via a protein kinase) activates myosin light chain phosphatase. • Myosin light chain phosphatase dephosphorylates myosin light chain fibres, causing smooth muscle relaxation/preventing constriction.

  4. Organic Nitrates – Extra Info • Preferential effect on veins (large increase in venous capacitance) – see Starling Curve. • GTN is inactivated when taken orally – must be delivered sublingually. • GTN works in 1-2 minutes, for 15-20 minutes. • ISMN is long-acting, can be taken orally. • Organic nitrates should only be given intermittently – vascular smooth muscle may become resistant, risk of abnormal constriction on withdrawal.

  5. Organic Nitrates – Side Effects • Vascular Headaches – caused by dilation of intercranial arteries • Tachycardia • Steal Syndrome – healthy blood vessels become dilated, diverting blood away from atheromatous vessels, resulting in less blood supply to these areas than was reaching there previously • Organic nitrates have limited potential for dilating sites of atheroma

  6. Treatment Options – ß-blockers • Atenolol, etc. • The Normal System • Activation of ß-adrenoreceptors (with G-coupled protein) activates adenylate cyclase. • Adenylate cyclase activates ATP  cAMP. • cAMP activates protein kinase A (PKA) • PKA causes an increase in heart rate and force of contraction. • Mechanism of Action • ß-blockers prevent the above from occurring, by blocking action at the ß-receptors.

  7. ß-blockers – Side Effects • Increase in left ventricular size – due to increase in LV work. • Bradycardia • Heart failure • Cold periphery

  8. Treatment Options – Ca2+ channel blockers • Verapamil & Diltiazem • Mechanism of Action • Reduce calcium entry to cardiac pacemaker cells, cardiac myocytes and vascular myocytes through L-gated calcium channels. • This causes the heart rate to slow, contraction force to be reduced and blood pressure to fall.

  9. Treatment Options – Ca2+ channel blockers • Nifedipine • Mechanism of Action • Reduces calcium entry to vascular myocytes through L-gated calcium channels. Has NO DIRECT EFFECT on cardiac cells themselves. • Nifedipine causes a fall in blood pressure.

  10. Ca2+ channel blockers – Side Effects • All: • Flushing • Headaches • Ankle swelling • Diltiazem/Verapamil: • Bradycardia • Heart failure • Nifedipine only: • Reflex techycardia

  11. Treatment Options - Other • Nicorandil (K+ channel opener) – vasodilator. • Can cause flushing, dizziness and severe headaches. • Ivabradine (Ifchannel blocker) – slows heart rate, relaxes coronary arteries. • Can cause bradycardia, heart block, headaches. • Ranolazine (reduces intracellular calcium via sodium-dependent calcium channels). • Can cause increased QT interval, vomiting, constipation, oedema, headaches, hypotension.

  12. Which Treatment When? • For Stable Angina • First line – ß-blocker or Ca2+ channel blocker • If not tolerated, reverse choice. • If not tolerated try ISMN, or Nicorandil, or Ivabradine, or Ranolazine – in that order.

  13. Which Treatment When? • For Unstable Angina • Antiplatelet treatment ASAP • Aspirin first line, then clopidrogrel • Anti-thrombin treatment • Heparin or direct thrombin inhibitor (e.g. bivalirudin) • Nitrates

  14. Myocardial Infarctions

  15. Treatment? • STEMI NSTEMI • Do immediate PCI (or if 90 mins has elapsed give thrombolysis). • Modify risk factors • Within 96 hours do PCI. • Modify risk factors

  16. For all acute coronary syndrome: • Reassurance • Oxygen • Morphine + antiemetic • Aspirin • Nitrates – IV or sublingual • Clopidogrel • Enoxaparin (LMW heparin)

  17. M.I. • Immediate • M – Morphine • O – Oxygen • N – Nitrates • A – Aspirin • Late • C – Clopidogrel • A – ACEi/ARBs • B – Beta Blockers • S – Statins

  18. Clot busters

  19. Anti-arrhythmics

  20. Cardiac Action Potential

  21. Class I Agents

  22. Class III Agents • Class II – ß-blockers (see earlier slides) • Class III block the potassium channels and thereby prolong repolarisation, but do not affect conduction velocity. They prevent re-entrant arrhythmias.

  23. Class IV Agents • Reduce amplitude and shorten phase 2 of the cardiac AP. As they reduce intracellular Ca2+ they are also negatively inotropic. • They also have an effect on pacemaker cells, slowing their overall conduction, so that they eventually have this effect:

  24. Heart Rate

  25. Atropine • Speed Up: Blocks the effects of Ach, so the heart beats faster • Used to treat Bradycardia! • ß-Blockers • Slow Down: blocks the sympathetic action on the heart • Used to treat atrial fibrillation! (among other things) Speed Up vs. Slow Down

  26. Ivabradine • Can also be used to treat arrhythmias. It only works on the SA node, slowing Na+ entry and thereby slowing pacemaker potential.

  27. Digoxin • Inhibits the Na+/K+ ATPase pump increased intracellular Na+ concentration stops passive exchange of Ca2+ for Na+increased intracellular Ca2+ concentration  positively inotropic, negatively chronotopic.

  28. Adenosine • Mechanism of Action • Bind to the A1 receptor in pacemaker tissue inhibits adenylyl cyclasereduces cAMPincreases efflux of K+cell hyperpolarisation. • It is primarily used to diagnose and treat AV node dependent tachycardias.

  29. Summary • Treatment options (and side effects) of main angina drugs. • MI immediate treatment. • Anti-arrhythmics – classifications, methods of action and effects of cardiac action potential.

  30. Any Questions?

More Related